Number of Shares
55,000.00
Current Holdings Value*
$675,680.00
% of Portfolio
4.31%
Total Estimate Gain
$-680,421.00
% of Total Estimate Gain
-43.93%

Lion Point Capital, LP's Syndax Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Lion Point Capital, LP held 55,000.00 shares of Syndax Pharmaceuticals Inc(SNDX), totaling $675,680.00. This investment constitutes 4.31% of their stock portfolio, and Lion Point Capital, LP now holds 0.06% of the outstanding Syndax Pharmaceuticals Inc(SNDX) stock.

The initial trade took place in 2023Q2. And since then Lion Point Capital, LP has made 3 purchases of SNDX, at an average price of $20.99, for a total of 73,800.00 shares. In addition, there have been 1 sales at an average price of $20.66 for 18,800.00 shares. Based on historical transaction data and SNDX's current price of $8.73, Lion Point Capital, LP's estimated gain on his SNDX holdings is $-680,421.00, reflecting a -43.93% gain to date.

Lion Point Capital, LP SNDX ($8.73) Holding Chart

Lion Point Capital, LP SNDX ($8.73) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1